痛みの知覚と気分に対する外部耳刺激の影響
Background:
The vagus nerve runs from the brain to many organs. Stimulating it can affect the experience of pain. The nerve can be stimulated on the surface of the left ear. Researchers want to study how this stimulation affects the perception of pain. They also want to study how mood affects the experience of pain.
Objective:
To study the effects of mood and vagus nerve stimulation on the experience of pain.
Eligibility:
Healthy people ages 18 and older who are fluent in English
Design:
Participants will be pre-screened with a 15-minute phone call.
Participants will have three 2-hour visits.
At the screening visit, participants will be screened with:
Medical and psychiatric history
Physical and psychological exams
Questionnaires about physical and psychiatric health and mood
Urine tests
A heat probe on the forearm. The temperature will be increased until it is painful
but tolerable.
Participants will have 2 testing sessions within 7 days. Before the testing, they cannot do the following:
Eat, use nicotine, or exercise for at least 2 hours
Drink alcohol for 24 hours
Take certain medicines for 3 days
Testing includes:
Urine drug screening
Left ear stimulation: In one session, the vagus nerve will be stimulated. In the other, an area
of the ear away from the vagus nerve will be stimulated. This will be done with mild electric
shocks that cause a tingling, pricking, or itchy feeling.
Heat applied to the forearm until it is painful but tolerable
Completing several forms on a computer or on paper about how they are feeling
Monitors on the chest and a finger clip to monitor heart, breathing, and blood pressure
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
This double-blind, randomized, controlled, cross-over study on healthy participants will evaluate the perceptual differences of pain and changes in mood in response to peripheral nerve stimulation over two regions of the left external ear. A series of short and long duration heat stimuli will be applied to the participants forearms and they will be asked to rate their current mood state, the intensity of the pain, and whether it was pleasant or unpleasant. The series of heat stimuli will be applied before, during, and after mild electrical stimulation of the left external ear using a commercially available TENS unit. There are two study sessions. Session 1 involves eligibility screening, a brief practice session, followed by the testing session. In Session 2 (no more than 7 days later), the testing session will be repeated with the exception of the location of ear stimulation. Up to 76 people, ages 18-50 years old, will be enrolled in the study.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
Maryland
-
Bethesda、Maryland、アメリカ、20892
- National Institutes of Health Clinical Center
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
- INCLUSION CRITERIA:
All subjects must be:
- between 18 and 50 years old.
- fluent in English.
- able to provide written informed consent.
EXCLUSION CRITERIA:
Overall exclusion criteria for the study
- Unable to comply with study procedures or visits (including inability to schedule the second session within 10 business days of the first session).
- Is pregnant or breastfeeding.
- Has ears with indiscernible structures (e.g., cymba conchae, earlobe) due to congenital malformations, accidents, or physical alterations (e.g., "gauge", cartilage piercing).
- Has a dermatological condition such as scars or burns, or has had a tattoo in the testing region within the previous four weeks that might influence cutaneous sensibility.
- Women who consume more than 7 alcoholic beverages per week, and men who consume more than 14 drinks per week.
- Has a current chronic pain condition or has had chronic pain in the past year (painful condition lasting more than six months).
- Has a major medical condition, such as kidney, liver, cardiovascular, autonomic, pulmonary, or neurological problems (e.g., epilepsy) or a chronic systemic disease (e.g., diabetes).
- Has or had psychiatric disorders such as major depression, major anxiety-related problems, post-traumatic stress syndrome, bipolar disorder, psychosis, or alcohol or substance abuse disorders as identified by the MINI International Neuropsychiatric Interview questionnaire, which will be administered as part of the screening procedure.
- Has a medical condition potentially affecting cardiac functioning (e.g. arrhythmias, bradycardia [<60 beats per min; determined during screening]) or Raynaud s Disease or other medical condition affecting peripheral vascular sensitivity.
- Is actively taking medications that are known to interfere with current measurements of pain or autonomic function. These include but are not limited to: opioids, antidepressants (such as tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin norepinephrine reuptake inhibitors), anticonvulsants (including gabapentin and pregabalin), and blood pressure medications (including beta-blockers, calcium channel blockers, and ACE inhibitors). Participants who have used such medications in the last three months must have ceased taking them for at least one month or three medication half-lives (whichever is longer) in order to be included.
- Baseline heat pain threshold exceeds 46 degrees C (to be determined after consent).
- Has ever had acupuncture in or around any area of the ears.
- NIH employees are subordinates, relatives, or co-workers of the investigators, or NCCIH DIR employees.
Exclusion criteria for individual study session*
-
Has consumed alcohol within 24 hours, shows signs of alcohol withdrawal syndrome, or has behavioral signs of intoxication.
-
Has exercised or eaten within two hours of testing session.
-
Used nicotinic substances (e.g., tobacco, gum, "e-cigarette") within 2 hours of testing.
-
Used topical pain-relieving creams in the testing area (e.g. methylsalicylate, capsaicin) within 24 hours of testing.
-
Used non-steroidal anti-inflammatory drugs (NSAIDS, e.g. aspirin, ibuprofen), acetaminophen, naproxen, sumatriptan within 3 days of testing.
- To be determined during the pre-session screening. Participants that cannot refrain from these activities may have their session rescheduled up to two times. If the participant is found non-compliant during the second rescheduled appointment, he or she will be excluded from the study.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:トリプル
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Cymba Conchae
Mild electrical stimulation is applied to the cymba conchae of the left ear, and thermal stimulation is applied to the arms. |
Mild transcutaneous electrical stimulation will be applied to the cymba conchae of the left ear on day 1 and the left earlobe on day 2 (or vice versa) using a commercially available TENS unit (transcutaneous electrical nerve stimulator) attached to a pair of silver electrodes. Device used to apply Thermal stimulation to both arms. |
|
アクティブコンパレータ:Ear Lobe
Mild electrical stimulation is applied to the earlobe of the left ear, and thermal stimulation is applied to the arms. |
Mild transcutaneous electrical stimulation will be applied to the cymba conchae of the left ear on day 1 and the left earlobe on day 2 (or vice versa) using a commercially available TENS unit (transcutaneous electrical nerve stimulator) attached to a pair of silver electrodes. Device used to apply Thermal stimulation to both arms. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The difference in pain ratings collected for each subject during the two types of left ear stimulation (cymba conchae and earlobe).
時間枠:End of study
|
See measures |
End of study
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The effect of tVNS on pain threshold, pain unpleasantness, and mood as measured by visual analogue scales (VAS).
時間枠:End of Study
|
See measures |
End of Study
|
|
Mood and anxiety, as measured by questionnaires taken at the beginning and end of both study sessions.
時間枠:End of study
|
See measures |
End of study
|
|
Autonomic measures will be analyzed to determine whether tVNS has an effect on heart rate variability.
時間枠:End of study
|
See measures |
End of study
|
協力者と研究者
スポンサー
スポンサー
捜査官
捜査官
- 主任研究者:Alisa J Johnson、National Center for Complementary and Integrative Health (NCCIH)
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (推定)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- 160136
- 16-AT-0136
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。